Market Cap
Roche Holding AG
CHF202.38 Billion
CHF as of Jan. 1, 2024
US$240.44 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
AbbVie | $285.06 B |
Novartis | $220.27 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Roche is a global healthcare company involved in prescription pharmaceuticals and diagnostics. It offers pharmaceutical products for a range of medical conditions, including oncology, neuroscience, infectious diseases, immunology, and ophthalmology. It also provides in vitro diagnostics solutions for several indications, supplies diagnostic instruments, reagents, consumables, and test kits for research, and collaborates with other companies for drug development.
Roche Holding AG has the following listings and related stock indices.
Stock: SIX: ROG
Stock: OTC: RHHBF
Stock: OTC: RHHBY
Stock: BMV: ROGN
Stock: SIX: RO
Stock: FSX: RHO6
Stock: OTC: RHHVF
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.